Sanofi (SNY)


NYSE - NYSE Real Time Price. Currency in USD
38.04-0.31 (-0.81%)
As of 1:00 PM EDT. Market open.
People also watch:
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open38.11
Prev Close38.35
Bid38.00 x 1400
Ask38.01 x 400
Day's Range37.94 - 38.15
52wk Range37.41 - 51.88
1y Target EstN/A
Market Cap97.91B
P/E Ratio (ttm)21.21
Beta0.90
Volume769,190
Avg Vol (3m)2,454,938
Dividend & Yield1.66 (4.34%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters1 hour ago

    Sanofi gets $43 mln U.S. funding to spur Zika vaccine development

    Sanofi SA said on Monday the U.S. Department of Health and Human Services approved $43.18 million in funding to accelerate the development of a Zika vaccine, as part of efforts to prevent the infection. The funding from the Biomedical Advanced Research and Development Authority (BARDA) will be used for mid-stage trials, expected to begin in the first half of 2018, and manufacturing, the French drugmaker said. Sanofi's vaccine unit, Sanofi Pasteur, said in February it intended to develop a Zika vaccine.

  • Barrons.com2 hours ago

    Pfizer: Split Decision

    Today, Pfizer (PFE) announced that plans to split the company in two are permanently on hold. Management has said previously that targets of all sizes are theoretically on the table - already this year, it announced it will spend ~$15B to buy Medivation (MDVN), and more transactions seem likely. A critic could argue that Pfizer is back to being the same old Pfizer as before, relying on M&A to grow and to refill its pipeline, but at the expense of growing larger in the process depending on the size of deals it chases.

  • The Internet of Medical Things: 6 Stocks in Focus
    Zacks3 hours ago

    The Internet of Medical Things: 6 Stocks in Focus

    Intelligent care is where modern medicine seems to be headed with pharma and tech companies collaborating for better healthcare solutions.